Process View
The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of systemic arterial blood pressure"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TGFB1 | transforming growth factor, beta 1 | 0.961 | ||
| ENG | endoglin | 0.605 | ||
| BMP2 | bone morphogenetic protein 2 | 0.461 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.400 | ||
| PPP2R5B | protein phosphatase 2, regulatory subunit B', beta | 0.355 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.351 | Human | |
| ADORA2A | adenosine A2a receptor | 0.347 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.342 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.290 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.269 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.234 | ||
| NRP1 | neuropilin 1 | 0.227 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.219 | ||
| AXL | AXL receptor tyrosine kinase | 0.216 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.194 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.106 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.093 | ||
| FSTL1 | follistatin-like 1 | 0.088 | ||
| ACVR1 | activin A receptor, type I | 0.079 | Human | |
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.077 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.074 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.071 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.067 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.064 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.063 | ||
| SDF2L1 | stromal cell-derived factor 2-like 1 | 0.060 | ||
| GDF5 | growth differentiation factor 5 | 0.057 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.056 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.052 | ||
| PDGFC | platelet derived growth factor C | 0.049 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.048 | Human | |
| BBS1 | Bardet-Biedl syndrome 1 | 0.047 | ||
| THBS1 | thrombospondin 1 | 0.047 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.043 | Mouse | |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.043 | ||
| WNK1 | WNK lysine deficient protein kinase 1 | 0.042 | Mouse | |
| ARRDC3 | arrestin domain containing 3 | 0.040 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.040 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.039 | ||
| PAX8 | paired box 8 | 0.038 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.038 | ||
| SMAD7 | SMAD family member 7 | 0.037 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.037 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.032 | ||
| TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | 0.029 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.029 | ||
| BBS2 | Bardet-Biedl syndrome 2 | 0.029 | ||
| BBS9 | Bardet-Biedl syndrome 9 | 0.027 | ||
| PRKCA | protein kinase C, alpha | 0.026 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.024 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.023 | ||
| HYOU1 | hypoxia up-regulated 1 | 0.023 | ||
| PRNP | prion protein | 0.023 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.022 | ||
| PSAP | prosaposin | 0.020 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.019 | ||
| EXOC7 | exocyst complex component 7 | 0.019 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.018 | Human | |
| TTC8 | tetratricopeptide repeat domain 8 | 0.018 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.018 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.017 | ||
| NCOA7 | nuclear receptor coactivator 7 | 0.017 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.017 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.017 | ||
| BMP4 | bone morphogenetic protein 4 | 0.017 | ||
| CALCRL | calcitonin receptor-like | 0.017 | ||
| PLG | plasminogen | 0.016 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.016 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.016 | ||
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.016 | ||
| C1QTNF1 | C1q and tumor necrosis factor related protein 1 | 0.015 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.015 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.015 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.014 | ||
| PURA | purine-rich element binding protein A | 0.014 | ||
| RARA | retinoic acid receptor, alpha | 0.014 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.014 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.013 | ||
| GLP1R | glucagon-like peptide 1 receptor | 0.013 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.013 | ||
| PGD | phosphogluconate dehydrogenase | 0.013 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.012 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.012 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.012 | ||
| CTDSP2 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 | 0.012 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.011 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.011 | Human | |
| GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 0.011 | ||
| EDNRB | endothelin receptor type B | 0.011 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| HDAC4 | histone deacetylase 4 | 0.011 | ||
| FHL2 | four and a half LIM domains 2 | 0.011 | ||
| IL8 | interleukin 8 | 0.011 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.011 | Human | |
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.011 | ||
| PPIB | peptidylprolyl isomerase B (cyclophilin B) | 0.011 | ||
| EZR | ezrin | 0.011 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.011 | ||
| SMAD1 | SMAD family member 1 | 0.010 | ||
| EDN3 | endothelin 3 | 0.010 | ||
| MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase | 0.010 | ||
| RET | ret proto-oncogene | 0.010 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.010 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.010 |